UAE Launches New Tool to Report Medicine Side Effects

New Digital Platform Makes Reporting Easier

The UAE has introduced a new digital service called EDE DAWA to help residents report suspected side effects linked to medicines and medical products.

The Emirates Drug Establishment (EDE) launched the tool as part of a nationwide campaign encouraging people to share their experiences.

Residents can access the service by scanning a campaign QR code or using the dedicated reporting pages on the EDE portal.

The information submitted will be forwarded to specialists for review and assessment through established procedures.

Campaign Encourages Residents to Speak Up

The initiative, titled “Speak Up…Stay Safe”, is being carried out with several UAE health authorities, including the Ministry of Health and Prevention, Emirates Health Services, Dubai Health Authority, Abu Dhabi’s Department of Health and Sharjah Health Authority.

It forms part of MedSafetyWeek 2026, taking place from November 2 to 8.

The campaign aims to remind patients, caregivers and healthcare professionals that reporting suspected side effects can contribute to better monitoring of medical product safety.

Workshops and Awareness Activities Planned

The programme includes online workshops for healthcare professionals on medicine safety monitoring and the handling of suspected side effects.

Awareness sessions and educational visits are also planned at the University of Sharjah to introduce students to pharmacovigilance and official reporting channels.

A separate virtual seminar will address the responsibilities of pharmaceutical companies and healthcare establishments.

These activities are intended to strengthen understanding of how safety information is collected and assessed.

Medicine Safety Monitoring Continues After Approval

EDE said monitoring does not stop once a medicine receives approval and becomes available in the market.

Reports from patients and healthcare professionals provide information that can be assessed alongside other scientific evidence to identify possible safety concerns.

The campaign also supports a national guide on good pharmacovigilance practices approved in July 2026.

Through easier reporting and stronger cooperation, the UAE aims to improve medicine safety and encourage responsible use of medical products.